title: Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
abstract: Silymarin, a mixture of polyphenolic flavonoids extracted from milk thistle (Silybum marianum), is composed mainly of silychristin, silydianin, silybin A, silybin B (SB(B)), isosilybin A (ISB(A)), and isosilybin B. In this study, the plasma concentrations of free (unconjugated), conjugated (sulfated and glucuronidated), and total (free and conjugated) silymarin flavonolignans were measured using liquid chromatography-electrospray ionization-mass spectrometry, after a single oral dose of 600 mg of standardized milk thistle extracts to three healthy volunteers. Pharmacokinetic analysis indicated that silymarin flavonolignans were rapidly eliminated with short half-lives (1-3 and 3-8 h for free and conjugated, respectively). The AUC(0-->infinity) values of the conjugated silymarin flavonolignans were 4- to 30-fold higher than those of their free fractions, with SB(B) (mean AUC(0-->infinity) = 51 and 597 microg x h/l for free and conjugated, respectively) and ISB(A) (mean AUC(0-->infinity) = 30 and 734 microg x h/l for free and conjugated, respectively) exhibiting higher AUC(0-->infinity) values in comparison with other flavonolignans. Near the plasma peak times (1-3 h), the free, sulfated, and glucuronidated flavonolignans represented approximately 17, 28, and 55% of the total silymarin, respectively. In addition, the individual silymarin flavonolignans exhibited quite different plasma profiles for both the free and conjugated fractions. These data suggest that, after oral administration, silymarin flavonolignans are quickly metabolized to their conjugates, primarily forming glucuronides, and the conjugates are primary components present in human plasma.
authors.affiliation: School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Zhiming
authors.initials: Z
authors.lastname: Wen
authors.forename: Todd E
authors.initials: TE
authors.lastname: Dumas
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Schrieber
authors.forename: Roy L
authors.initials: RL
authors.lastname: Hawke
authors.forename: Michael W
authors.initials: MW
authors.lastname: Fried
authors.forename: Philip C
authors.initials: PC
authors.lastname: Smith
mesh_terms: D000284:Administration, Oral; D019540:Area Under Curve; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D006801:Humans; D020944:Silybum marianum / Q000737:chemistry*; D015394:Molecular Structure; D010936:Plant Extracts / Q000737:chemistry / Q000592:standards; D012838:Silymarin / Q000097:blood* / Q000302:isolation & purification / Q000378:metabolism / Q000493:pharmacokinetics* / Q000592:standards; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D010936:Plant Extracts; D012838:Silymarin